Cellular Biomedicine Group, Inc. was incorporated in Delaware in November 2004. Our R&D operations are located in Shanghai, People’s Republic of China. We focus on cell therapy development for the treatment of cancer, orthopedic/spine, metabolic, anti-inflammatory, and other degenerative diseases.
